Seiji Kojima

1.5k total citations
40 papers, 1.1k citations indexed

About

Seiji Kojima is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Seiji Kojima has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 10 papers in Genetics and 10 papers in Immunology. Recurrent topics in Seiji Kojima's work include Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (6 papers) and Transplantation: Methods and Outcomes (5 papers). Seiji Kojima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Mesenchymal stem cell research (6 papers) and Transplantation: Methods and Outcomes (5 papers). Seiji Kojima collaborates with scholars based in Japan, United States and United Kingdom. Seiji Kojima's co-authors include Hiromasa Yabe, Naoto Hirano, Yusuke Okuno, Eva C. Guinan, Marcus O. Butler, Lee M. Nadler, Seishi Ogawa, Kenichi Yoshida, Kenichi Chiba and Satoru Miyano and has published in prestigious journals such as Blood, Journal of Neurochemistry and The Journal of Infectious Diseases.

In The Last Decade

Seiji Kojima

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seiji Kojima Japan 20 414 308 220 213 175 40 1.1k
Mitsuhiro Fukata Japan 13 502 1.2× 440 1.4× 276 1.3× 354 1.7× 149 0.9× 54 1.3k
Asahito Hama Japan 22 887 2.1× 340 1.1× 286 1.3× 222 1.0× 289 1.7× 106 1.4k
Jun Miyauchi Japan 18 671 1.6× 357 1.2× 258 1.2× 205 1.0× 75 0.4× 50 1.1k
Yao-Qi Huang United States 15 543 1.3× 445 1.4× 158 0.7× 241 1.1× 239 1.4× 17 1.2k
Suhag Parikh United States 17 527 1.3× 227 0.7× 238 1.1× 120 0.6× 327 1.9× 74 1.1k
Shunya Arai Japan 19 629 1.5× 678 2.2× 195 0.9× 183 0.9× 241 1.4× 51 1.3k
Kenneth Langlands United Kingdom 16 289 0.7× 413 1.3× 91 0.4× 127 0.6× 77 0.4× 39 977
José Luís Fuster Spain 18 399 1.0× 255 0.8× 163 0.7× 299 1.4× 184 1.1× 60 937
Masatsugu Ohta Japan 20 375 0.9× 930 3.0× 398 1.8× 337 1.6× 113 0.6× 49 1.6k
A Tobler Switzerland 11 349 0.8× 216 0.7× 235 1.1× 225 1.1× 64 0.4× 21 890

Countries citing papers authored by Seiji Kojima

Since Specialization
Citations

This map shows the geographic impact of Seiji Kojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Kojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Kojima more than expected).

Fields of papers citing papers by Seiji Kojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Kojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Kojima. The network helps show where Seiji Kojima may publish in the future.

Co-authorship network of co-authors of Seiji Kojima

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Kojima. A scholar is included among the top collaborators of Seiji Kojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Kojima. Seiji Kojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Lei, Fengkui Zhang, & Seiji Kojima. (2020). Current insights into the treatments of severe aplastic anemia in China. International Journal of Hematology. 112(3). 292–299. 9 indexed citations
2.
Suzuki, Michio, Tadashi Takeda, Seiko Iwata, et al.. (2015). The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas. Frontiers in Microbiology. 6. 280–280. 20 indexed citations
3.
Kato, Taichi, et al.. (2015). Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects. Journal of Thoracic and Cardiovascular Surgery. 150(3). 645–654.e3. 40 indexed citations
4.
Hira, Asuka, Kenichi Yoshida, Koichi Sato, et al.. (2015). Mutations in the Gene Encoding the E2 Conjugating Enzyme UBE2T Cause Fanconi Anemia. The American Journal of Human Genetics. 96(6). 1001–1007. 89 indexed citations
5.
Sanefuji, Masafumi, Hidetaka Akiyoshi, Kenichiro Yamamura, et al.. (2012). Bilateral stenosis of carotid siphon in Hutchinson-Gilford progeria syndrome. Brain and Development. 35(7). 690–693. 4 indexed citations
6.
Sakaguchi, Hirotoshi, Koji Nakanishi, & Seiji Kojima. (2012). Inherited bone marrow failure syndromes in 2012. International Journal of Hematology. 97(1). 20–29. 20 indexed citations
7.
Yoshida, Nao, Sayoko Doisaki, & Seiji Kojima. (2012). Current Management of Juvenile Myelomonocytic Leukemia and the Impact of RAS Mutations. Pediatric Drugs. 14(3). 157–163. 12 indexed citations
8.
Yoshimi, Ayami, Seiji Kojima, Shuichi Taniguchi, et al.. (2008). Unrelated Cord Blood Transplantation for Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 14(9). 1057–1063. 69 indexed citations
9.
Sato, Yoshiaki, Keiko Nakanishi, Masahiro Hayakawa, et al.. (2008). Reduction of Brain Injury in Neonatal Hypoxic—Ischemic Rats by Intracerebroventricular Injection of Neural Stem/Progenitor Cells Together With Chondroitinase ABC. Reproductive Sciences. 15(6). 613–620. 38 indexed citations
10.
Sato, Yoshiaki, Keiko Nakanishi, Yoshihito Tokita, et al.. (2007). A highly sulfated chondroitin sulfate preparation, CS‐E, prevents excitatory amino acid‐induced neuronal cell death. Journal of Neurochemistry. 104(6). 1565–1576. 39 indexed citations
11.
Yoshimi, Ayami, et al.. (2005). Leukemic cell death induced by antithymocyte globulin. Leukemia Research. 29(7). 821–827. 10 indexed citations
12.
Kojima, Seiji, Norbert Frickhofen, H. Joachim Deeg, et al.. (2005). Aplastic Anemia. International Journal of Hematology. 82(5). 408–411. 11 indexed citations
13.
Kimura, Hiroshi, Shinya Hara, Yo Hoshino, et al.. (2004). Quantitative Analysis of Epstein‐Barr Virus (EBV)–Specific CD8+T Cells in Patients with Chronic Active EBV Infection. The Journal of Infectious Diseases. 190(5). 985–988. 51 indexed citations
14.
Kondo, Masaru, Seiji Kojima, Keizo Horibe, Koji Kato, & T Matsuyama. (1998). Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies. Bone Marrow Transplantation. 21(3). 281–286. 20 indexed citations
15.
Shichino, Hiroyuki, Hideo Mugishima, Takashi Suzuki, et al.. (1996). Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazole and recombinant human granulocyte‐colony stimulating factor. Pediatrics International. 38(6). 644–647. 3 indexed citations
16.
Kojima, Seiji, et al.. (1996). Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML.. PubMed. 18(2). 449–52. 2 indexed citations
17.
18.
Kojima, Seiji, Takaharu Matsuyama, & Yoshihisa Kodera. (1995). Circulating Erythropoietin in Patients with Acquired Aplastic Anaemia. Acta Haematologica. 94(3). 117–122. 3 indexed citations
19.
Kojima, Seiji, et al.. (1989). Circulating activated suppressor T lymphocytes in hepatitis‐associated aplastic anaemia. British Journal of Haematology. 71(1). 147–151. 17 indexed citations
20.
Kojima, Seiji, et al.. (1978). [Clinical evaluation of amoxicillin tablets (Widecillin tablets) in pediatric field (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 31(10). 601–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026